Patients with blood cancers and some rare genetic diseases will benefit from a $49.6 million funding boost for innovative new cell and gene therapies in the 2020-21 NSW Budget.
Last updated: 04/02/2021
Patients with blood cancers and some rare genetic diseases will benefit from a $49.6 million funding boost for innovative new cell and gene therapies in the 2020-21 NSW Budget.
Last updated: 04/02/2021
NSW Treasury pays respect to the Traditional Custodians and First Peoples of NSW and acknowledges their continued connection to country and culture.
